Management of Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombus: Current Evidence and Future Perspectives—A Narrative Review
Hiroyuki Kato, Zenichi Morise, Yutaro Kato, Hidetoshi Katsuno, Masahiro Ito, Akihiko Horiguchi · 2026
Read Management of Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombus: Current Evidence and Future Perspectives—A Narrative Review by Hiroyuki Kato, Zenichi Morise, Yutaro Kato, Hidetoshi Katsuno, Masahiro Ito, Akihiko Horiguchi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13464424.txt.
Description
Hiroyuki Kato and five co-authors review care for liver cancer that has invaded the portal vein, the liver's main inflow vessel. Such invasion marks advanced disease with fast spread and poor survival. Drugs remain the default, yet the review asks which patients might still gain from surgery or mixed approaches.
Treatment paths now blend surgery, radiation, vessel-directed therapy, and modern immune drugs in planned sequences. Care before surgery can shrink disease enough to allow a full removal, a route called conversion surgery. Practice differs between Asian and Western centers on how boldly to operate. The authors close with a team-based frame that weighs tumor extent, liver strength, drug response, and patient fitness together.
Catalog record
| CREATOR | Hiroyuki Kato, Zenichi Morise, Yutaro Kato, Hidetoshi Katsuno, Masahiro Ito, Akihiko Horiguchi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38377 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |